Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016632
Filing Date
2022-08-11
Accepted
2022-08-11 07:01:26
Documents
71
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q acst-20220630.htm   iXBRL 10-Q 2409396
2 EX-31.1 acst-ex31_1.htm EX-31.1 16592
3 EX-31.2 acst-ex31_2.htm EX-31.2 16555
4 EX-32.1 acst-ex32_1.htm EX-32.1 13842
5 EX-32.2 acst-ex32_2.htm EX-32.2 15118
6 GRAPHIC img179496299_0.jpg GRAPHIC 84300
7 GRAPHIC img179496299_1.jpg GRAPHIC 22519
8 GRAPHIC img179496299_2.jpg GRAPHIC 54176
9 GRAPHIC img179496299_3.jpg GRAPHIC 57139
10 GRAPHIC img179496299_4.jpg GRAPHIC 50485
11 GRAPHIC img179496299_5.jpg GRAPHIC 14782
12 GRAPHIC img179496299_6.jpg GRAPHIC 76885
13 GRAPHIC img179496299_7.jpg GRAPHIC 56008
14 GRAPHIC img179496299_8.jpg GRAPHIC 65524
15 GRAPHIC img179496299_9.jpg GRAPHIC 44285
16 GRAPHIC img179496299_10.jpg GRAPHIC 54177
17 GRAPHIC img179496299_11.jpg GRAPHIC 41281
  Complete submission text file 0000950170-22-016632.txt   8119501

Data Files

Seq Description Document Type Size
18 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acst-20220630.xsd EX-101.SCH 35454
19 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acst-20220630_pre.xml EX-101.PRE 210128
20 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acst-20220630_lab.xml EX-101.LAB 260019
21 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acst-20220630_cal.xml EX-101.CAL 36161
22 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acst-20220630_def.xml EX-101.DEF 140650
65 EXTRACTED XBRL INSTANCE DOCUMENT acst-20220630_htm.xml XML 1046525
Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5
Business Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-35776 | Film No.: 221153615
SIC: 2834 Pharmaceutical Preparations